Table 3. Risk of all-cause and CVD mortality based on metabolic syndrome and its components in all participants and separately in men and women .
| Variable | Men | Women | All subjects | |||
| HR (95%CI) | p | HR (95%CI) | p | HR (95%CI) | p | |
| All-cause mortality | ||||||
| Age (years) | 1.10 (1.06–1.12) | <0.0001 | 1.10 (1.06–1.15) | <0.0001 | 1.09 (1.07 – 1.11) | <0.0001 |
| High TG | 1.71 (0.48 – 2.83) | 0.73 | 0.8 (0.27–2.32) | 0.67 | 1.003(0.51 – 1.97) | 0.990 |
| Low HDL-C | 1.2 (0.49–2.93) | 0.70 | 1.34 (0.18–10.16) | 0.78 | 1.03 (0.48–2.2) | 0.930 |
| IFG | 2.33 (0.91–5.9 ) | 0.076 | 2.8 (0.99 – 7.9) | 0.051 | 2.53(1.27 – 5.06) | 0.009 |
| Hypertension | 5.17 (2.11–12.65) | <0.0001 | 5.96 (2.12–16.77) | 0.001 | 5.53 (2.81–10.87) | <0.0001 |
| WC | 1.37 (0.4 – 4.66) | 0.62 | 1.67 (0.61– 4.61) | 0.32 | 1.27 (0.62–2.6) | 0.500 |
| Metabolic syndrome | 1.6 (0.66 – 3.87) | 0.29 | 2.3 (0.72 – 7.1) | 0.16 | 1.75 (0.88–3.47) | 0.110 |
| Age (years) | 1.10 (1.04–1.14 ) | <0.0001 | 1.10 (1.06–1.15) | <0.0001 | 1.10 (1.07 – 1.15) | <0.0001 |
| Cardiovascular mortality | ||||||
| High TG | 2.19 (0.62 – 7.7) | 0.23 | 0.80 (0.27 – 2.32) | 0.52 | 1.88 (0.74 – 4.78) | 0.180 |
| Low HDL-C | 3.24 (0.69 – 15.28) | 0.14 | 1.34 (0.18 – 10.16) | 0.57 | 2.87 (0.66 – 12.5) | 0.160 |
| IFG | 2.10 (0.52 – 8.4 ) | 0.29 | 2.80 (0.99 – 7.9) | 0.008 | 3.72 (1.43 – 9.65) | 0.007 |
| Hypertension | 8.45 (2.18 – 32.73) | 0.002 | 5.96 (2.12 – 16.77) | 0.009 | 7.60 (2.85 – 20.27) | <0.0001 |
| WC | 1.97 (0.42 – 9.29) | 0.4 | 1.67 (0.61 – 4.61) | 0.58 | 1.39 (0.52 – 3.72) | 0.500 |
| Metabolic syndrome | 3.20 (0.82 – 12.25) | 0.95 | 2.30 (0.72 – 7.1) | 0.1 | 3.66 (1.2 – 11.1) | 0.020 |